Group Leader in Chemical Proteomics, Dr. Guillaume Médard, and his research group in the lab. (IMAGE)

Technical University of Munich (TUM)

Group Leader in Chemical Proteomics, Dr. Guillaume Médard, and his research group in the lab.

Caption

Group Leader in Chemical Proteomics, Dr. Guillaume Médard, and his research group in the lab. An international research team has now investigated the effects of some HDAC drugs in more detail. The scientists researched whether those epidrugs affect proteins other than the HDACs which they are designed to inhibit.

Credit

U. Benz / TUM

Usage Restrictions

Free for use in reporting on TUM with copyright noted.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.